Compugen Ltd. (CGEN)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
6.30+0.07 (+1.12%)
At close: 4:00PM EDT
6.34 +0.04 (0.63%)
Pre-Market: 08:41AM EDT
Pre-Market: 08:41AM EDT
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 6.23 |
| Open | 6.29 |
| Bid | 6.03 x 900 |
| Ask | 7.00 x 1200 |
| Day's Range | 6.23 - 6.39 |
| 52 Week Range | 5.76 - 18.75 |
| Volume | 301,982 |
| Avg. Volume | 736,034 |
| Market Cap | 527.158M |
| Beta (5Y Monthly) | 2.31 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.39 |
| Earnings Date | May 13, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 20.86 |
- PR Newswire
Compugen to Present at the Cantor Global Healthcare Conference
Compugen Ltd. (NASDAQ: CGEN), a leader in predictive discovery and development of first-in-class therapeutics for cancer immunotherapy, today announced that management will present at the Cantor Global Healthcare Conference on Thursday, September 30, 2021 at 1:20 pm ET.
- Simply Wall St.
Here's Why We Think Compugen Ltd.'s (NASDAQ:CGEN) CEO Compensation Looks Fair for the time being
Performance at Compugen Ltd. ( NASDAQ:CGEN ) has been reasonably good and CEO Anat Cohen-Dayag has done a decent job of...
- PR Newswire
Compugen to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
Compugen Ltd. (NASDAQ: CGEN), a leader in predictive discovery and development of first-in-class therapeutics for cancer immunotherapy, today announced that management will present at the Morgan Stanley 19th Annual Global Healthcare Conference (virtual), on Thursday, September 9, 2021 at 11:00 am ET.
© 2021 Verizon Media. All rights reserved.
